Search

Your search keyword '"Cadman J"' showing total 29 results
Start Over Author "Cadman J" Journal gmhc treatment issues the gay mens health crisis newsletter of experimental aids therapies
29 results on '"Cadman J"'

2. Obstacles to treatment success.

Author

Cadman J

Subjects
Clinical Competence, Drug Therapy, Combination, Humans, Medication Errors, Viral Load, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, Patient Compliance
Published
1998

3. A long wait for Ritonavir capsules.

Author

Cadman J

Subjects
Biological Availability, Capsules, Crystallization, Humans, Quality Control, HIV Infections drug therapy, HIV Protease Inhibitors administration & dosage, Ritonavir administration & dosage
Published
1998

4. A rocky road for nucleotide analogs.

Author

Cadman J

Subjects
Adenine administration & dosage, Antiviral Agents administration & dosage, Cidofovir, Clinical Trials as Topic, Humans, AIDS-Related Opportunistic Infections drug therapy, Adenine adverse effects, Antiviral Agents adverse effects, Cytomegalovirus Retinitis drug therapy, Cytosine adverse effects, HIV Infections drug therapy, Organophosphonates, Organophosphorus Compounds adverse effects
Published
1998

5. NNRTIs: a neglected class.

Author

Cadman J

Subjects
Alkynes, Benzoxazines, Clinical Trials as Topic, Cyclopropanes, Drug Resistance, Microbial, Drug Therapy, Combination, Humans, Delavirdine therapeutic use, HIV Infections drug therapy, Nevirapine therapeutic use, Oxazines therapeutic use, Reverse Transcriptase Inhibitors therapeutic use
Published
1998

6. Set back for nerve growth factor.

Author

Cadman J

Subjects
Clinical Trials as Topic, Drug Industry, Humans, Peripheral Nervous System Diseases etiology, HIV Infections complications, Nerve Growth Factors therapeutic use, Peripheral Nervous System Diseases drug therapy
Published
1998

7. Debate widens over protease inhibitor side effects.

Author

Cadman J

Subjects
Drug Therapy, Combination, HIV Infections metabolism, HIV Protease Inhibitors metabolism, HIV Protease Inhibitors therapeutic use, Human Growth Hormone therapeutic use, Humans, Hyperlipidemias chemically induced, Pancreatitis chemically induced, Switzerland, Adipose Tissue pathology, HIV Infections drug therapy, HIV Protease Inhibitors adverse effects
Published
1998

8. Ritonavir users put on liquid diet.

Author

Cadman J

Subjects
Capsules, Drug Storage, Humans, HIV Infections drug therapy, HIV Protease Inhibitors administration & dosage, Ritonavir administration & dosage, Solutions administration & dosage
Published
1998

9. Working to improve pregnancy outcomes.

Author

Cadman J

Subjects
Drug Therapy, Combination, Female, Humans, Infant, Newborn, Pregnancy, Switzerland, Anti-HIV Agents therapeutic use, Cesarean Section, HIV Infections prevention & control, HIV Infections transmission, Infectious Disease Transmission, Vertical prevention & control, Pregnancy Outcome, Zidovudine therapeutic use
Published
1998

10. U.N. drug initiative hits the ground.

Author

Cadman J

Subjects
Anti-HIV Agents economics, Anti-HIV Agents therapeutic use, Clinical Trials as Topic, Drug Therapy, Combination, Female, HIV Infections prevention & control, Humans, Infant, Newborn, Infectious Disease Transmission, Vertical prevention & control, International Cooperation, National Health Programs economics, Pregnancy Complications, Infectious drug therapy, Sexually Transmitted Diseases drug therapy, Zidovudine economics, Zidovudine supply & distribution, Zidovudine therapeutic use, AIDS-Related Opportunistic Infections drug therapy, Anti-HIV Agents supply & distribution, Developing Countries, HIV Infections drug therapy, Health Services Accessibility, National Health Programs organization & administration, United Nations
Published
1998

11. Diarrhea drug rejection raises a ruckus.

Author

Cadman J

Subjects
Clinical Trials as Topic, Diarrhea microbiology, Drug Approval, Humans, United States, United States Food and Drug Administration, AIDS-Related Opportunistic Infections complications, Antiprotozoal Agents therapeutic use, Cryptosporidiosis complications, Diarrhea drug therapy, Thiazoles therapeutic use
Published
1998

12. On the road with protease inhibitors.

Author

Cadman J

Subjects
Drug Administration Schedule, Drug Storage, Humans, Patient Compliance, HIV Infections drug therapy, HIV Protease Inhibitors administration & dosage, Travel
Published
1998

13. The great salvage therapy drug juggle.

Author

Cadman J

Subjects
Clinical Trials as Topic, Decision Making, Drug Resistance, Microbial, Drug Therapy, Combination, Humans, Viral Load, HIV Infections drug therapy, HIV Protease Inhibitors therapeutic use, HIV-1 drug effects, Salvage Therapy
Published
1998

14. Vertical transmission research at the Retrovirus Conference.

Author

Cadman J

Subjects
Anti-HIV Agents administration & dosage, Clinical Trials as Topic, Didanosine therapeutic use, Drug Resistance, Microbial, Female, HIV Infections drug therapy, Humans, Infant, Newborn, Maternal-Fetal Exchange, Pregnancy, Pregnancy Complications, Infectious drug therapy, Viral Load, Zidovudine administration & dosage, Anti-HIV Agents therapeutic use, HIV Infections prevention & control, HIV Infections transmission, Infectious Disease Transmission, Vertical prevention & control, Zidovudine therapeutic use
Published
1998

15. Looking down the drug pipeline.

Author

Cadman J

Subjects
Adenine administration & dosage, Adenine analogs & derivatives, Adenine therapeutic use, Animals, Anti-HIV Agents administration & dosage, Biological Availability, Chlorobenzenes administration & dosage, Chlorobenzenes therapeutic use, Clinical Trials as Topic, Codon, Granulocyte-Macrophage Colony-Stimulating Factor therapeutic use, HIV Protease Inhibitors administration & dosage, Humans, Naphthalenes administration & dosage, Naphthalenes therapeutic use, Organophosphonates administration & dosage, Organophosphonates therapeutic use, Pyrimidinones, Receptors, CCR5 metabolism, Receptors, CXCR4 metabolism, Reverse Transcriptase Inhibitors administration & dosage, Reverse Transcriptase Inhibitors therapeutic use, Tenofovir, Anti-HIV Agents therapeutic use, Dideoxyadenosine analogs & derivatives, Drug Resistance, Microbial, Drugs, Investigational, HIV Infections drug therapy, HIV Protease Inhibitors therapeutic use
Published
1998

16. Efavirenz pregnancy warning.

Author

Cadman J

Subjects
Alkynes, Animals, Benzoxazines, Cyclopropanes, Female, Haplorhini, Humans, Male, Pregnancy, Pregnancy Complications, Infectious, Abnormalities, Drug-Induced, HIV Infections drug therapy, Oxazines adverse effects, Reverse Transcriptase Inhibitors adverse effects
Published
1998

17. 2, 4, 6, 8, who's afraid to phosphorylate?

Author

Cadman J

Subjects
Biotransformation, Clinical Trials as Topic, Drug Interactions, Drug Resistance, Microbial, Drug Therapy, Combination, Humans, Mutation, Phosphorylation, Prodrugs metabolism, Treatment Failure, Virus Replication, Anti-HIV Agents pharmacokinetics, HIV Infections drug therapy, Zidovudine pharmacokinetics
Published
1998

18. Reevaluating initial therapy.

Author

Cadman J

Subjects
CD4 Lymphocyte Count, Clinical Trials as Topic, DNA, Viral analysis, Didanosine therapeutic use, Drug Resistance, Microbial, Drug Therapy, Combination, HIV Protease Inhibitors therapeutic use, Humans, Lamivudine therapeutic use, Polymerase Chain Reaction, Stavudine therapeutic use, Viral Load, Zidovudine therapeutic use, Anti-HIV Agents therapeutic use, HIV Infections drug therapy
Published
1998

19. Optimizing PCP therapy.

Author

Torres G and Cadman J

Subjects
AIDS-Related Opportunistic Infections prevention & control, Aerosols, Antifungal Agents administration & dosage, Atovaquone, CD4 Lymphocyte Count, Clinical Trials as Topic, Dapsone therapeutic use, Drug Administration Schedule, Encephalitis drug therapy, Encephalitis prevention & control, Humans, Naphthoquinones therapeutic use, Pentamidine administration & dosage, Pneumonia, Pneumocystis prevention & control, Toxoplasmosis drug therapy, Toxoplasmosis prevention & control, Trimethoprim, Sulfamethoxazole Drug Combination administration & dosage, AIDS-Related Opportunistic Infections drug therapy, Antifungal Agents therapeutic use, Pentamidine therapeutic use, Pneumonia, Pneumocystis drug therapy, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use
Published
1997

20. CMV trials struggle to enroll.

Author

Cadman J

Subjects
CD4 Lymphocyte Count, Humans, Prodrugs therapeutic use, AIDS-Related Opportunistic Infections drug therapy, Adenine therapeutic use, Antiviral Agents therapeutic use, Clinical Trials as Topic, Cytomegalovirus Infections drug therapy, Ganciclovir therapeutic use
Published
1997

21. Candidiasis in immune-compromised women.

Author

Cadman J

Subjects
AIDS-Related Opportunistic Infections drug therapy, Antifungal Agents therapeutic use, CD4 Lymphocyte Count, Candidiasis drug therapy, Drug Resistance, Microbial, Female, Fluconazole therapeutic use, Humans, Immunocompromised Host, Risk Factors, AIDS-Related Opportunistic Infections immunology, Candidiasis immunology
Published
1997

22. Rapid advances in preventing vertical transmission.

Author

Cadman J

Subjects
Animals, Drug Therapy, Combination, Female, HIV Protease Inhibitors therapeutic use, Humans, Immunoglobulins therapeutic use, Infant, Newborn, Lamivudine therapeutic use, Mice, Nevirapine therapeutic use, Patient Selection, Pregnancy, Reverse Transcriptase Inhibitors therapeutic use, Risk Factors, Viral Load, Anti-HIV Agents therapeutic use, Clinical Trials as Topic, HIV Infections prevention & control, HIV Infections transmission, Infectious Disease Transmission, Vertical prevention & control, Pregnancy Complications, Infectious, Zidovudine therapeutic use
Published
1997

23. Early treatment for HIV-infected infants.

Author

Cadman J

Subjects
Adult, Disease Progression, Female, HIV Infections transmission, Humans, Infant, Newborn, Infectious Disease Transmission, Vertical prevention & control, Male, Predictive Value of Tests, Viral Load, HIV Infections diagnosis, HIV Infections drug therapy
Published
1997

24. Ganciclovir implants: one year later.

Author

Cadman J

Subjects
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome complications, Acquired Immunodeficiency Syndrome drug therapy, Anti-HIV Agents therapeutic use, Antiviral Agents adverse effects, Antiviral Agents therapeutic use, CD4 Lymphocyte Count, Clinical Trials as Topic, Cytomegalovirus Infections complications, Cytomegalovirus Retinitis complications, Drug Implants, Eye, Ganciclovir adverse effects, Ganciclovir therapeutic use, Humans, Retinal Detachment etiology, Antiviral Agents administration & dosage, Cytomegalovirus Infections drug therapy, Cytomegalovirus Retinitis drug therapy, Ganciclovir administration & dosage
Published
1997

26. Some relief from the epidemic.

Author

Cadman JA

Subjects
Acquired Immunodeficiency Syndrome drug therapy, Acquired Immunodeficiency Syndrome epidemiology, Anti-HIV Agents therapeutic use, Centers for Disease Control and Prevention, U.S., Drug Costs, Drug Therapy, Combination, Female, HIV Infections drug therapy, HIV Protease Inhibitors therapeutic use, Health Services Accessibility, Hospitalization statistics & numerical data, Humans, Lamivudine therapeutic use, Male, New York City epidemiology, Population Surveillance, Prevalence, United States epidemiology, AIDS-Related Opportunistic Infections prevention & control, Acquired Immunodeficiency Syndrome mortality
Published
1997

27. A NAC for controversy.

Author

Gilden D and Cadman J

Subjects
Acetylcysteine therapeutic use, CD4 Lymphocyte Count, Clinical Trials, Phase I as Topic, Disease Progression, Female, Humans, Male, United States, Viral Load, Acetylcysteine pharmacology, Glutathione biosynthesis, Glutathione pharmacology, HIV Infections drug therapy
Published
1997

28. Improved ganciclovir regimens.

Author

Cadman J

Subjects
Administration, Oral, Clinical Trials as Topic, Drug Implants, Humans, Prodrugs, AIDS-Related Opportunistic Infections drug therapy, Antiviral Agents administration & dosage, Cytomegalovirus Retinitis drug therapy, Ganciclovir administration & dosage
Published
1997

29. CMV viremia: a look at the other viral load.

Author

Cadman J

Subjects
AIDS-Related Opportunistic Infections drug therapy, Antiviral Agents, Clinical Trials as Topic, Cytomegalovirus Infections drug therapy, Disease Progression, Ganciclovir administration & dosage, Humans, Predictive Value of Tests, Viremia, AIDS-Related Opportunistic Infections virology, Cytomegalovirus Infections virology, Polymerase Chain Reaction methods, Viral Load
Published
1997

Catalog

Books, media, physical & digital resources
See catalog results